All analysis on the Genomics England dataset happens within a secure, cloud workspace called the Research Environment. To access the data, researchers must first apply to become a member of either the ...

We have developed a machine learning tool for scanning large volumes of scientific literature to find reports of gene-disease ...

We're working in partnership with NHS England and the NHS Genomic Medicine Service to develop a personalised and predictive healthcare solution through the use of genomics. Genomic medicine uses ...

Our vision is that all patients, regardless of their background, receive the same quality of genomics-enabled personalised medicine, supported by the latest research on people like them.

Genomics England's very first initiative – sequencing 100,000 genomes from around 85,000 NHS patients affected by rare disease or cancer – is leading to groundbreaking insights and continued findings ...

There are thousands of potential conditions that can be tested for through genome sequencing. It was important for us to carefully consider which conditions should be looked for in the Generation ...

Genomic medicine is already helping more people receive answers about their health conditions through better diagnosis, treatment, and support. By volunteering to take part in research, you'll be ...

Every year hundreds of babies are born in the UK with rare genetic conditions. Early intervention can enhance the health and quality of life of many of these babies. But these conditions can be hard ...

Join one of the Research Network communities to collaborate with fellow researchers, share skills and expertise, and learn about the latest developments and opportunities in the community.

The Participant Panel is made up of a diverse group of people whose data is held in the National Genomic Research Library. Members come from different walks of life and bring their life experiences of ...

Genomics England's very first initiative – sequencing 100,000 genomes from around 85,000 NHS patients affected by rare disease or cancer – is leading to groundbreaking insights and continued findings ...